Survey: Performance Improvement Required to Transform Cost Structures, Invest in Future Business Models

CHICAGO, Oct. 22, 2019 /PRNewswire/ — Nearly all U.S. hospitals (96%) now recognize the importance of, and have set, cost reduction targets, yet fewer than 1 in 4 respondents have achieved “most” or “all” of their cost transformation goals, especially in non-traditional, high-opportunity cost reduction areas — such as lowering unwarranted clinical variation — according to Kaufman Hall’s new report, done in collaboration with the Healthcare Financial Management Association (HFMA), 2019 State of Healthcare Performance Improvement: Strategy, Technology, and Tactics.

The report is Kaufman Hall’s third annual in-depth look at priorities healthcare executives are setting and progress they are making toward improving organizational performance. This year’s data was collected in partnership with Kaufman Hall / Axiom and HFMA, resulting in a larger data set than in previous years. The results indicate that hospitals should embrace opportunities for more meaningful gains, such as obtaining more valuable data insights, demanding greater accountability for performance improvement goals among leadership, and delivering better information to support physician engagement.

Healthcare organizations under increasing pressure
Hospitals face multiple revenue and expense challenges that underscore the need for cost transformation. Chief among the revenue challenges, according to the survey, are flat or declining inpatient volumes, which 30% of respondents listed as their top concern. Closely following are downward pressure on commercial insurance rates (27%), and an increasing percentage of Medicare and Medicaid patients (19%).

At the same time, almost one-half of respondents (47%) said rising salary and wage inflation, the result of a tight labor market, makes it more difficult to hold the line on expenses. Since labor costs account for up to 60% of a hospital’s expenses, this trend is a direct threat to cost transformation efforts. Additionally, 23% of respondents say that demands for capital to fund strategic initiatives are putting pressure on their bottom line.

“This report demonstrates that while healthcare finance executives understand the need for performance improvement, the pathway to achieving these goals is still filled with obstacles,” said Lance Robinson, managing director at Kaufman Hall. “Changing business models as more care migrates beyond hospital walls, combined with an aging population more reliant on programs like Medicare and Medicaid, make it imperative to control costs in legacy operations and free up resources to invest in the future. Better data and insights are key to helping healthcare leaders identify and prioritize both cost reduction and business growth opportunities.”

Technology on the rise
As the recognized need for cost transformation continues to grow, so does the focus on technology that will enable it. In fact, nearly three out of four (73%) respondents said they will invest in cost transformation technology within the next two years. Yet when asked if their organizations have access to reliable, trusted costing data, as many answered “no” as “yes” (47% each, with the final 6% saying they didn’t know).

Having reliable, trusted data is core to any analytics effort, and especially to one as complex as cost transformation. The report recommends that organizations pursuing a more detailed understanding of costs adopt a tiered approach — matching intensity of effort with items that have the highest impact on decision making.

“A detailed and in-depth understanding of costs is essential for all healthcare provider organizations today,” said HFMA President and CEO Joseph J. Fifer, FHFMA, CPA. “But specific organizational needs vary depending on market conditions and other circumstances. Prioritizing analytics needs helps organizations avoid extraneous data and move forward more effectively.”     

Opportunities and struggles collide
When asked in which areas their organizations had made the greatest strides in reducing costs, 36% of executives surveyed said “labor cost/productivity” and 32% said “supply chain and other non-labor costs” – both traditional areas of focus. At the same time, 31% said they had the most difficulty in achieving their labor cost/productivity cost transformation goals.

One other major area of opportunity is reducing unwarranted clinical variation. While it was recognized as a high potential opportunity, it was also identified as one of the areas where respondents faced the most difficulty in achieving their cost transformation goals. It was tied for last in areas where respondents had achieved their greatest cost transformation success.

“We believe the mechanisms enabling cost transformation are better understood now than ever before,” said Kermit S. Randa, chief executive officer, Kaufman Hall Software. “Hospitals continue to proceed cautiously, but the fact that they are taking cost transformation seriously is a step in the right direction. Our hope is that the 2020 report will show even more progress and a greater commitment to making the transformational changes required to thrive in a healthcare future that will look very different from today.”

To download a copy, visit 2019 Kaufman Hall Performance Improvement.

Kaufman Hall and HFMA will co-host a webinar, titled 2019 Performance Improvement Insights: Strategy, Technology, and Tactics that Drive Cost Transformation on November 21, 2019 at 1 PM CT.

About Kaufman Hall
Kaufman Hall provides a unique combination of software, management consulting and data solutions to help society’s foundational institutions realize sustained success amid changing market conditions. Since 1985, Kaufman Hall has been a trusted advisor to boards and executive management teams, helping them incorporate proven methods, rigorous analytics and industry-leading solutions into their strategic planning and financial management processes, with a focus on achieving their most challenging goals.

Kaufman Hall services use a rigorous, disciplined, and structured approach that is based on the principles of corporate finance. The breadth and integration of Kaufman Hall advisory services are unparalleled, encompassing strategy; financial and capital planning; cost transformation; treasury and capital markets management; and mergers, acquisitions, partnerships, and joint ventures.

Kaufman Hall software includes the Axiom Software Suite, providing sophisticated, flexible performance management solutions that empower finance professionals to analyze results, model the future, and optimize organizational decision making. Solutions for long-range planning, budgeting and forecasting, performance reporting, capital planning, and cost accounting deliver decision support, reporting, and analytics within an integrated software platform. Kaufman Hall’s Clinical Analytics empower healthcare organizations with clinical benchmarks, data, and analytics to provide a higher quality of care for optimized performance and improved patient outcomes.

Press Contact:
Philip Anast
Amendola Communications (for Kaufman Hall)
Email: panast@acmarketingpr.com 
Phone: 312-576-6990

View original content to download multimedia:http://www.prnewswire.com/news-releases/survey-performance-improvement-required-to-transform-cost-structures-invest-in-future-business-models-300943287.html

SOURCE Kaufman Hall

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

6 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

7 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

7 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

8 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

10 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

10 hours ago